193 related articles for article (PubMed ID: 36310151)
1. Metabolic Rewiring of Kynurenine Pathway during Hepatic Ischemia-Reperfusion Injury Exacerbates Liver Damage by Impairing NAD Homeostasis.
Xu B; Zhang P; Tang X; Wang S; Shen J; Zheng Y; Gao C; Mi P; Zhang C; Qu H; Li S; Yuan D
Adv Sci (Weinh); 2022 Dec; 9(35):e2204697. PubMed ID: 36310151
[TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD
Berge RK; Cacabelos D; Señarís R; Nordrehaug JE; Nygård O; Skorve J; Bjørndal B
Lipids Health Dis; 2020 May; 19(1):94. PubMed ID: 32410680
[TBL] [Abstract][Full Text] [Related]
3. NAMPT inhibition reduces macrophage inflammation through the NAD+/PARP1 pathway to attenuate liver ischemia-reperfusion injury.
Lu J; Wang M; Chen Y; Song H; Wen D; Tu J; Guo Y; Liu Z
Chem Biol Interact; 2023 Jan; 369():110294. PubMed ID: 36460127
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine 3-monooxygenase limits de novo NAD
Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ
Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways.
Oxenkrug G
Mol Neurobiol; 2013 Oct; 48(2):294-301. PubMed ID: 23813101
[TBL] [Abstract][Full Text] [Related]
6. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury.
Zhang XJ; Cheng X; Yan ZZ; Fang J; Wang X; Wang W; Liu ZY; Shen LJ; Zhang P; Wang PX; Liao R; Ji YX; Wang JY; Tian S; Zhu XY; Zhang Y; Tian RF; Wang L; Ma XL; Huang Z; She ZG; Li H
Nat Med; 2018 Jan; 24(1):73-83. PubMed ID: 29227475
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS.
van der Velpen V; Rosenberg N; Maillard V; Teav T; Chatton JY; Gallart-Ayala H; Ivanisevic J
J Neurochem; 2021 Oct; 159(2):378-388. PubMed ID: 33829502
[TBL] [Abstract][Full Text] [Related]
8. Effects of Kynurenine Pathway Metabolites on Intracellular NAD Synthesis and Cell Death in Human Primary Astrocytes and Neurons.
Braidy N; Grant R; Brew BJ; Adams S; Jayasena T; Guillemin GJ
Int J Tryptophan Res; 2009; 2():61-9. PubMed ID: 22084582
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
[TBL] [Abstract][Full Text] [Related]
10. A Minimal Kynurenine Pathway Was Preserved for Rhodoquinone but Not for
Comas-Ghierra R; Alshaheeb A; McReynolds MR; Shepherd JN; Salinas G
Antioxid Redox Signal; 2024 May; 40(13-15):737-750. PubMed ID: 37639366
[No Abstract] [Full Text] [Related]
11. Kynurenine pathway in Parkinson's disease-An update.
Venkatesan D; Iyer M; Narayanasamy A; Siva K; Vellingiri B
eNeurologicalSci; 2020 Dec; 21():100270. PubMed ID: 33134567
[TBL] [Abstract][Full Text] [Related]
12. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Kynurenine and NAD
Wnorowski A; Wnorowska S; Kurzepa J; Parada-Turska J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948292
[TBL] [Abstract][Full Text] [Related]
14. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
Front Immunol; 2020; 11():31. PubMed ID: 32153556
[TBL] [Abstract][Full Text] [Related]
15. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway.
Colín-González AL; Luna-López A; Königsberg M; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2014 Feb; 260():130-9. PubMed ID: 24361737
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine pathway, NAD
Castro-Portuguez R; Sutphin GL
Exp Gerontol; 2020 Apr; 132():110841. PubMed ID: 31954874
[TBL] [Abstract][Full Text] [Related]
17. De novo NAD
Wan J; Cheng C; Hu J; Huang H; Han Q; Jie Z; Zou Q; Shi JH; Yu X
Cell Rep; 2023 Dec; 42(12):113518. PubMed ID: 38041812
[TBL] [Abstract][Full Text] [Related]
18. Increased fatty acid oxidation and mitochondrial proliferation in liver are associated with increased plasma kynurenine metabolites and nicotinamide levels in normolipidemic and carnitine-depleted rats.
Lindquist C; Bjørndal B; Lund A; Slettom G; Skorve J; Nygård O; Svardal A; Berge RK
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158543. PubMed ID: 31676443
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
20. Macrophage de novo NAD
Minhas PS; Liu L; Moon PK; Joshi AU; Dove C; Mhatre S; Contrepois K; Wang Q; Lee BA; Coronado M; Bernstein D; Snyder MP; Migaud M; Majeti R; Mochly-Rosen D; Rabinowitz JD; Andreasson KI
Nat Immunol; 2019 Jan; 20(1):50-63. PubMed ID: 30478397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
